Alendronate vs Denosumab: Comparing Long-Term Efficacy, Safety, and Costs for Osteoporosis
Jun 2 2025
Generic substitution saves money but increases legal risk for pharmacists. Learn how state laws, high-risk drugs, and documentation practices affect liability-and what steps you can take to protect yourself and your patients.
Studies show that switching to generic versions of narrow therapeutic index (NTI) drugs like warfarin, phenytoin, and cyclosporine can lead to dangerous fluctuations in blood levels. Learn what the evidence says about clinical outcomes, risks, and how to protect yourself.
Physicians prescribing generic medications face rising legal risks as federal law shields manufacturers from liability. Learn how to protect yourself with proper documentation, high-risk drug awareness, and updated prescribing practices.
Jun 2 2025
Jan 13 2026
Dec 31 2025
Sep 25 2025
Dec 15 2025